Journey Medical Corp Quarterly Nonoperating Income (Expense) in USD from Q3 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Journey Medical Corp quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2020 to Q2 2024.
  • Journey Medical Corp Nonoperating Income (Expense) for the quarter ending June 30, 2024 was -$434K, a 38.9% increase year-over-year.
  • Journey Medical Corp Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was -$1.06M, a 57.5% increase year-over-year.
  • Journey Medical Corp annual Nonoperating Income (Expense) for 2023 was -$1.56M, a 23.9% increase from 2022.
  • Journey Medical Corp annual Nonoperating Income (Expense) for 2022 was -$2.05M, a 72.6% increase from 2021.
  • Journey Medical Corp annual Nonoperating Income (Expense) for 2021 was -$7.48M, a 971% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$1.06M -$434K +$276K +38.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$1.34M -$352K +$223K +38.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$1.56M $87K +$721K Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 -$2.28M -$361K +$217K +37.5% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 -$2.5M -$710K -$260K -57.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$2.24M -$575K -$189K -49% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 -$2.05M -$634K +$3.73M +85.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 -$5.77M -$578K +$797K +58% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$6.57M -$450K +$1.07M +70.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$7.64M -$386K -$165K -74.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-22
Q4 2021 -$7.48M -$4.36M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$1.38M -$1.19M -635% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$1.52M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$221K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q3 2020 -$187K Jul 1, 2020 Sep 30, 2020 10-Q 2021-12-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.